Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Lung Neoplasms 58Carcinoma, Non-Small-Cell Lung 53Breast Neoplasms 19Pancreatic Neoplasms 11Small Cell Lung Carcinoma 9Ovarian Neoplasms 9Melanoma 9Colorectal Neoplasms 8Colonic Neoplasms 8Stomach Neoplasms 7Sarcoma 7Head and Neck Neoplasms 7Neoplasms 6Pleural Effusion, Malignant 5Mesothelioma 5Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 4Adenocarcinoma of Lung 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Osteosarcoma 3Neoplasm Metastasis 3Glioblastoma 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Rectal Neoplasms 2Pulmonary Disease, Chronic Obstructive 2NSCLC 2

Interventions

perflutren 1Sulfur Hexafluoride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Emphysema × Thoracic × Clear all
NCT02748798 2024-10-15

Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders

Thunder Bay Regional Health Research Institute

Phase EARLY_PHASE1 Terminated
10 enrolled
Other solid neoplasmThoracic

Asbestosis, Asthma, Bronchiectasis, Cystic Fibrosis, Emphysema, Rhinitis, Allergic, Seasonal, Hypertension, Pulmonary, Lung Neoplasms, Mesothelioma, Pulmonary Embolism, Pulmonary Fibrosis, Lung Diseases, Interstitial, Sleep Apnea, Obstructive, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡